Mark Bach, MD, PhD

Mark Bach is Chief Medical Officer for GentiBio. He is a physician scientist trained as a pediatric endocrinologist and has 30 years of pharmaceutical development experience in the US and globally. Mark joins us from Structure Therapeutics, where he was CMO, and prior to this, held clinical development leadership roles at Ascendis Pharma as SVP, Endocrine Medical Sciences, Janssen as Head of Asia Pacific Medical Science and Merck as head of global Clinical Research Operations. Dr. Bach received an M.D. from Baylor College of Medicine, a Ph.D. in pathology from The University of Chicago, and a B.A. in chemistry from Carleton College. In his spare time, Mark likes cooking, baking, photography, bicycling, and travel.